Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma
Clinical trial NCT01009203 · TERMINATED
Trial details
- NCT number
- NCT01009203
- Sponsor
- New Mexico Cancer Research Alliance
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2012-09-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.